Work

Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations

Year: 2016

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd.2015.35

Author: Axel Hoos

Institution: GlaxoSmithKline (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Association for Cancer Research, Sabin Vaccine Institute

OpenAlex ID: W2296047035

FWCI: 7.321

Cites: 131

Cited by: 603

Related to: 10